Media headlines about Innospec (NASDAQ:IOSP) have trended somewhat positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Innospec earned a daily sentiment score of 0.10 on Accern’s scale. Accern also assigned media stories about the specialty chemicals company an impact score of 59 out of 100, indicating that recent news coverage is somewhat likely to have an impact on the stock’s share price in the next few days.
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
- Innospec Inc. (NASDAQ:IOSP) Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPS (americanbankingnews.com)
- Innospec Reports Second Quarter 2017 Financial Results (finance.yahoo.com)
- Innospec posts 2Q profit (finance.yahoo.com)
- Innospec Inc. (IOSP) Given Average Recommendation of “Buy” by Analysts (americanbankingnews.com)
- Innospec Inc. (NASDAQ:IOSP) Stock Rating Lowered by ValuEngine (americanbankingnews.com)
Innospec (IOSP) opened at 63.40 on Wednesday. Innospec has a one year low of $54.45 and a one year high of $74.75. The stock has a 50 day moving average of $64.23 and a 200-day moving average of $65.13. The firm has a market capitalization of $1.53 billion, a PE ratio of 19.45 and a beta of 1.15.
Innospec (NASDAQ:IOSP) last released its quarterly earnings data on Tuesday, August 8th. The specialty chemicals company reported $1.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.08. Innospec had a return on equity of 14.63% and a net margin of 8.24%. On average, equities analysts predict that Innospec will post $4.12 EPS for the current year.
Several analysts have recently weighed in on IOSP shares. Zacks Investment Research upgraded shares of Innospec from a “hold” rating to a “strong-buy” rating and set a $73.00 price objective for the company in a research report on Tuesday, May 16th. BidaskClub downgraded shares of Innospec from a “hold” rating to a “sell” rating in a research report on Thursday, June 22nd. Finally, ValuEngine downgraded shares of Innospec from a “buy” rating to a “hold” rating in a research report on Monday.
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with our FREE daily email newsletter.